Skip to content
HowShorted

ROCKET PHARMACEUTICALS, INC. short interest in 2021

In 2021, ROCKET PHARMACEUTICALS, INC.'s disclosed short interest ran from 14.92% of shares outstanding on 15 Jan 2021 to 12.21% on 31 Dec 2021, a change of -2.71 percentage points. The year's high was 15.95% on 31 Mar 2021 and its low 11.92% on 15 Nov 2021, averaging 13.24% across 24 twice-monthly settlement dates. FINRA's days-to-cover figure peaked at 38.71 days on 28 May 2021. Full history: ROCKET PHARMACEUTICALS, INC..

Cite this page
Plain
Wikipedia
BibTeX

By year: 2019 · 2020 · 2021 · 2022 · 2023 · 2024 · 2025 · 2026

Aggregate net short position time series for ROCKET PHARMACEUTICALS, INC. in 2021

2021 in figures

Start of year
14.92% (15 Jan 2021)
End of year
12.21% (31 Dec 2021)
Change
-2.71 pp
High
15.95% (31 Mar 2021)
Low
11.92% (15 Nov 2021)
Average
13.24%
Highest days to cover
38.71 (28 May 2021)
SEC filings marked
7

Every report in 2021

ROCKET PHARMACEUTICALS, INC. short interest in 2021
SettlementShort interestDays to coverFilings since previous
15 Jan 202114.92%17.02
29 Jan 202115.02%19.85
12 Feb 202114.82%23.90
26 Feb 202114.94%18.46
15 Mar 202114.89%19.7310-K filed
31 Mar 202115.95%15.43
15 Apr 202114.88%18.13
30 Apr 202114.42%27.69
14 May 202112.83%15.8810-Q filed, results (8-K)
28 May 202112.71%38.71
15 Jun 202112.57%32.50
30 Jun 202112.07%22.71
15 Jul 202112.03%19.33
30 Jul 202112.65%17.27
13 Aug 202112.14%13.3310-Q filed, results (8-K)
31 Aug 202112.41%12.85
15 Sep 202112.43%21.46
30 Sep 202112.73%23.62
15 Oct 202112.28%28.06
29 Oct 202112.38%29.79
15 Nov 202111.92%18.26results (8-K), 10-Q filed
30 Nov 202112.00%17.11
15 Dec 202112.54%20.55
31 Dec 202112.21%9.66

See also: ROCKET PHARMACEUTICALS, INC.'s full history · most shorted US stocks of 2021 · today's US league.

About this data

US short interest data: FINRA (finra.org), shown as reported shares short divided by SEC-reported shares outstanding for each settlement date. FINRA® is a registered trademark of the Financial Industry Regulatory Authority, Inc. This site is not affiliated with or endorsed by FINRA or the SEC; displayed for personal reference, bulk redistribution is not permitted (see terms). Nothing here is investment advice. Method: methodology.